This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamazaki, H
Right arrow Articles by Shibuya, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamazaki, H
Right arrow Articles by Shibuya, M

 Previous Article  |  Next Article 

Mol Cell Biol. 1988 April; 8(4): 1816-1820

Amplification of the structurally and functionally altered epidermal growth factor receptor gene (c-erbB) in human brain tumors.

H Yamazaki, Y Fukui, Y Ueyama, N Tamaoki, T Kawamoto, S Taniguchi and M Shibuya

Department of Genetics, University of Tokyo, Japan.

ABSTRACT

By using Southern blot analysis, we found that in two cases of human glioblastoma multiforme, cells carried amplified c-erbB genes which bore short deletion mutations within the ligand-binding domain of the epidermal growth factor (EGF) receptor. The products of these mutated c-erbB genes were about 30 kilodalton (kDa) smaller than the normal 170-kDa EGF receptor, and the tumor cell membrane fractions containing the 140-kDa abnormal EGF receptor showed a significant elevation of tyrosine kinase activity without its ligand. In view of the similarity to the activated viral and cellular erbB genes in the avian system, these mutated and overexpressed EGF receptors might play a role in the onset or development of human glioblastoma cells.

Mol Cell Biol. 1988 April; 8(4): 1816-1820




This article has been cited by other articles:

  • Micallef, J., Taccone, M., Mukherjee, J., Croul, S., Busby, J., Moran, M. F., Guha, A. (2009). Epidermal Growth Factor Receptor Variant III-Induced Glioma Invasion Is Mediated through Myristoylated Alanine-Rich Protein Kinase C Substrate Overexpression. Cancer Res. 69: 7548-7556 [Abstract] [Full Text]  
  • Steffensen, K. D., Waldstrom, M., Olsen, D. A., Corydon, T., Lorentzen, K. A., Knudsen, H. J., Jeppesen, U., Brandslund, I., Jakobsen, A. (2008). Mutant Epidermal Growth Factor Receptor in Benign, Borderline, and Malignant Ovarian Tumors. Clin. Cancer Res. 14: 3278-3282 [Abstract] [Full Text]  
  • Mellinghoff, I. K., Cloughesy, T. F., Mischel, P. S. (2007). PTEN-Mediated Resistance to Epidermal Growth Factor Receptor Kinase Inhibitors. Clin. Cancer Res. 13: 378-381 [Abstract] [Full Text]  
  • Mamot, C., Drummond, D. C., Noble, C. O., Kallab, V., Guo, Z., Hong, K., Kirpotin, D. B., Park, J. W. (2005). Epidermal Growth Factor Receptor-Targeted Immunoliposomes Significantly Enhance the Efficacy of Multiple Anticancer Drugs In vivo. Cancer Res. 65: 11631-11638 [Abstract] [Full Text]  
  • Jiang, J., Greulich, H., Janne, P. A., Sellers, W. R., Meyerson, M., Griffin, J. D. (2005). Epidermal Growth Factor-Independent Transformation of Ba/F3 Cells with Cancer-Derived Epidermal Growth Factor Receptor Mutants Induces Gefitinib-Sensitive Cell Cycle Progression. Cancer Res. 65: 8968-8974 [Abstract] [Full Text]  
  • Paez, J. G., Janne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., Naoki, K., Sasaki, H., Fujii, Y., Eck, M. J., Sellers, W. R., Johnson, B. E., Meyerson, M. (2004). EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy. Science 304: 1497-1500 [Abstract] [Full Text]  
  • Abroun, S., Ishikawa, H., Tsuyama, N., Liu, S., Li, F.-J., Otsuyama, K.-i., Zheng, X., Obata, M., Kawano, M. M. (2004). Receptor synergy of interleukin-6 (IL-6) and insulin-like growth factor-I in myeloma cells that highly express IL-6 receptor {alpha}. Blood 103: 2291-2298 [Abstract] [Full Text]  
  • Mamot, C., Drummond, D. C., Greiser, U., Hong, K., Kirpotin, D. B., Marks, J. D., Park, J. W. (2003). Epidermal Growth Factor Receptor (EGFR)-targeted Immunoliposomes Mediate Specific and Efficient Drug Delivery to EGFR- and EGFRvIII-overexpressing Tumor Cells. Cancer Res. 63: 3154-3161 [Abstract] [Full Text]  
  • Jungbluth, A. A., Stockert, E., Huang, H. J. S., Collins, V. P., Coplan, K., Iversen, K., Kolb, D., Johns, T. J., Scott, A. M., Gullick, W. J., Ritter, G., Cohen, L., Scanlan, M. J., Cavenee, W. K., Old, L. J. (2003). A monoclonal antibody recognizing human cancers with amplification/overexpression of the human epidermal growth factor receptor. Proc. Natl. Acad. Sci. USA 100: 639-644 [Abstract] [Full Text]  
  • Snitkovsky, S., Niederman, T. M. J., Carter, B. S., Mulligan, R. C., Young, J. A. T. (2000). A TVA-Single-Chain Antibody Fusion Protein Mediates Specific Targeting of a Subgroup A Avian Leukosis Virus Vector to Cells Expressing a Tumor-Specific Form of Epidermal Growth Factor Receptor. J. Virol. 74: 9540-9545 [Abstract] [Full Text]  
  • Frederick, L., Eley, G., Wang, X.-Y., James, C. D. (2000). Analysis of genomic rearrangements associated with EGFRvIII expression suggests involvement of Alu repeat elements. Neuro Oncol Duke 2: 159-163 [Abstract]  
  • Tang, C. K., Gong, X.-Q., Moscatello, D. K., Wong, A. J., Lippman, M. E. (2000). Epidermal Growth Factor Receptor vIII Enhances Tumorigenicity in Human Breast Cancer. Cancer Res. 60: 3081-3087 [Abstract] [Full Text]  
  • Frederick, L., Wang, X.-Y., Eley, G., James, C. D. (2000). Diversity and Frequency of Epidermal Growth Factor Receptor Mutations in Human Glioblastomas. Cancer Res. 60: 1383-1387 [Abstract] [Full Text]  
  • Archer, G. E., Sampson, J. H., Lorimer, I. A. J., McLendon, R. E., Kuan, C.-T., Friedman, A. H., Friedman, H. S., Pastan, I. H., Bigner, D. D. (1999). Regional Treatment of Epidermal Growth Factor Receptor vIII-expressing Neoplastic Meningitis with a Single-Chain Immunotoxin, MR-1. Clin. Cancer Res. 5: 2646-2652 [Abstract] [Full Text]  
  • Shintani, S., Matsuo, K., Crohin, C. C., McBride, J., Tsuji, T., Donoff, R. B., Posner, M., Todd, R., Wong, D. T.W. (1999). Intragenic Mutation Analysis of the Human Epidermal Growth Factor Receptor (EGFR) Gene in Malignant Human Oral Keratinocytes. Cancer Res. 59: 4142-4147 [Abstract] [Full Text]  
  • Moscatello, D. K., Holgado-Madruga, M., Emlet, D. R., Montgomery, R. B., Wong, A. J. (1998). Constitutive Activation of Phosphatidylinositol 3-Kinase by a Naturally Occurring Mutant Epidermal Growth Factor Receptor. J. Biol. Chem. 273: 200-206 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»